AlgaeCal Inc.   Report issue

For profit Phase 1
Founded: Vancouver BC Canada (2004)
Status: Left NME R&D (2009)

Organization Overview

First Clinical Trial
2006
NCT01114685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

algaecal (2 trials)

calcium (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2